{
    "nct_id": "NCT03297125",
    "official_title": "Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n* Newly diagnosed glioblastoma (GBM), World Health Organization (WHO) grade IV.\n\nExclusion Criteria:\n\n* Optune compliance \\< 75%; they would be excluded from the final analyses.\n* History of craniectomy or significant skull defect (contraindication to Optune).\n* Active implantable medical device (e.g., deep brain stimulator (DBS), spinal cord stimulator, pacemaker, defibrillator, vagus nerve stimulator, programmable shunt).\n* Karnofsky Performance Status (KPS) \\< 60.\n\nsex: ALL\n\nminimumAge: 18 Years\n\nstdAges: ['ADULT', 'OLDER_ADULT']",
        "inclusion": "* Newly diagnosed glioblastoma (GBM), World Health Organization (WHO) grade IV.",
        "exclusion": "* Optune compliance < 75%; they would be excluded from the final analyses.\n* History of craniectomy or significant skull defect (contraindication to Optune).\n* Active implantable medical device (e.g., deep brain stimulator (DBS), spinal cord stimulator, pacemaker, defibrillator, vagus nerve stimulator, programmable shunt).\n* Karnofsky Performance Status (KPS) < 60."
    }
}